heme-displacing IDO1 inhibitor
human predicted QD dose of 26 mg
from 260k MS-based screen and SBDD
ACS Med. Chem. Lett. Mar. 10, 2020
Merck, Boston, MA
Merck IDO1 inhibitor
1 min read
Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)
Search By Structure
- CC-92480
- “PROTAC 6”
- GSK620
- Merck hArg1 inhibitor
- Merck IDO1 inhibitor
- Constellation EZH2 inhibitor
- Arcus CD73 inhibitor
- MK-6884
- Sulfopin
- M3814
- Remibrutinib
Molecules of the Month
2023
2022
2021
2020